News Room

Wednesday, June 13, 2007

Vioxx Lawyers are Still Helping Victims Get Their Due

Vioxx was one of the most widely prescribed pain relievers of our time. It was also a very significant pharmaceutical mistake by a major drug manufacturer. Nearly 20 million people looked to the drug to help deal with their osteoarthritis, rheumatoid arthritis, or other sources of pain. After the Food and Drug Administration reviewed the data accumulated by Merck , the company had to withdraw Vioxx from the market due to the increased risks of heart attacks. Contacting an experienced Vioxx attorney is the only way you’ll see restitution since Merck now insists that it will defend any Vioxx claim in court. It is important that you act quickly since all personal injury suits are subject to a statute of limitations.

The staff at Lipsig, Shapey, Manus & Moverman are dedicated New York Vioxx lawyers available to fight for your rights. Our experienced Vioxx lawyers understand the feelings that occur when a drug you’re taking to help your pain ends up causing more serious medical problems or even death. Vioxx was taken off the market on September 30, 2004, but the pain afflicted to people who had adverse reactions to Vioxx continues.

If you or a family member suffered a heart attack, stroke or other ailment associated with Vioxx, or if someone in your family suffered a fatality because of it, don’t delay in contacting an experienced New York Vioxx attorney at Lipsig, Shapey, Manus & Moverman today.

We work on a contingency basis, which means that you don’t pay a cent until you receive compensation, at which point you are charged a percentage of the settlement.

There is no fee for our services unless a recovery is won.

We offer a free initial consultation. If you feel that you, or a family member, had an adverse reaction to Vioxx and wish to bring legal action for compensation, Click here to contact our Vioxx lawyers for legal representation. You may also call toll free at: 1-800-9-LIPSIG for a free consultation.

Technorati tags:

No comments: